Interleukin-33 and heart health in ankylosing spondylitis
Part of Bones, joints & muscles clinical trials.
This study looks at a protein called interleukin-33 in people with ankylosing spondylitis (a type of arthritis affecting the spine) and whether it is linked to early signs of heart disease. It aims to find out if this protein could help predict heart problems in people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ankylosing spondylitis
- You are between 20 and 40 years old
- You do not have any other type of arthritis or related condition
- You have not had a heart attack, stroke, or other heart or blood vessel event
- You have not had heart surgery or a cerebrovascular procedure in the last 6 months
- You do not have other risk factors for heart disease (like high cholesterol, diabetes, or smoking)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the level of a protein called IL-41 in the blood of people with ankylosing spondylitis or psoriatic arthritis, compared to healthy people. The goal is to see if this protein could be used as a marker to help understand or diagnose these conditions.
This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.
This study looks at a specific white blood cell (called neutrophils) in people with ankylosing spondylitis. By measuring a marker called Tim-3 on these cells, researchers hope to learn more about the disease, which could help improve future treatments.
This study compares two types of biologic drugs (IL-17 inhibitors vs. anti-TNF drugs) in people with ankylosing spondylitis (a form of arthritis affecting the spine) who have already tried standard treatments. The goal is to see which drug works better for controlling symptoms.
This study looks at the levels of a specific enzyme (15-hydroxyprostaglandin dehydrogenase) in the blood and joints of people with osteoarthritis or ankylosing spondylitis. The goal is to see if this enzyme can help tell these conditions apart or show how active they are.
This study looks at how heart health risks and healthy lifestyle habits (like diet, exercise, and not smoking) relate to people with ankylosing spondylitis. It may help you understand how to better manage your overall health.
Hear when a new Ankylosing Spondylitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.